The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Novel gene delivery systems
Abstract
Gene therapy is an emerging field in medical and pharmaceutical sciences because of its potential in treating chronic diseases like cancer, viral infections, myocardial infarctions, and genetic disorders. Application of gene therapy is limited because of lack of suitable methods for proper introduction of genes into cells and therefore, this is an area of interest for most of the researchers. To achieve successful gene therapy, development of proper gene delivery systems could be one of the most important factors. Several nonviral and viral gene transfer methods have been developed. Even though the viral agents have a high transferring efficiency, they are difficult to handle due to their toxicity. To overcome the safety problems of the viral counterpart, several nonviral in vitro and in vivo gene delivery systems are developed. Out of these, the most promising and latest systems include polymer-based nonviral gene carriers, dendrimers, and physical means like electroporation, microinjection, etc., Shunning of possible immunogenicity and toxicity, and the feasibility of repeated administration are some of the merits of nonviral gene delivery systems over viral gene delivery. An ideal nonviral gene carrying system should possess all these merits without any compromise to its gene transferring efficiency. The viral gene delivery systems include lytic and nonlytic vectors for drug delivery. Inspite of its toxicity they are still preferred because of their long term expression, stability, and integrity. This review explores the recent developments and relevancy of the novel gene delivery systems in gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though said techniques are widely used in research labs, these shortcomings combined with low efficiency limit their use in human gene therapy [143,144].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [143]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research
Gehl, J. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01093.x · Cited by 973
Current status of polymeric gene delivery systems☆
PARK, T., JEONG, J., & KIM, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.007 · Cited by 944
A Polyamidoamine Dendrimer-Capped Mesoporous Silica Nanosphere-Based Gene Transfection Reagent
Radu, D. R., Lai, C.-Y., Jeftinija, K., Rowe, E. W., Jeftinija, S., & Lin, V. S.-Y. (2004) · Journal of the American Chemical Society · doi:10.1021/ja046275m · Cited by 840
Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells
Zhou, W., & Freed, C. R. (2009) · Stem Cells · doi:10.1002/stem.201 · Cited by 538 · cited 1×
“[4] Most of the adenoviral gene delivery is being aimed for cancer chemotherapy.”
Micelles and nanoparticles for ultrasonic drug and gene delivery
Husseini, G. A., & Pitt, W. G. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.008 · Cited by 468
Swift, S., Lorens, J., Achacoso, P., & Nolan, G. P. (1999) · Current Protocols in Immunology · doi:10.1002/0471142735.im1017cs31 · Cited by 313
A novel magnetic crystal–lipid nanostructure for magnetically guided in vivo gene delivery
Namiki, Y., Namiki, T., Yoshida, H., Ishii, Y., Tsubota, A., Koido, S., Nariai, K., Mitsunaga, M., Yanagisawa, S., Kashiwagi, H., et al. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.202 · Cited by 243
Exosomes as nano-theranostic delivery platforms for gene therapy
Tan, A., Rajadas, J., & Seifalian, A. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.014 · Cited by 242
Chlorotoxin Labeled Magnetic Nanovectors for Targeted Gene Delivery to Glioma
Kievit, F. M., Veiseh, O., Fang, C., Bhattarai, N., Lee, D., Ellenbogen, R. G., & Zhang, M. (2010) · ACS Nano · doi:10.1021/nn1008512 · Cited by 222
Akhtar, S., & Benter, I. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.010 · Cited by 219
Vectors and delivery systems in gene therapy.
Gardlík, R., Pálffy, R., Hodosy, J., Lukács, J., Turňa, J., & Celec, P. (2005) · PubMed · Cited by 219
Theoretical and computational studies of dendrimers as delivery vectors
Tian, W.-D., & Ma, Y.-Q. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35306g · Cited by 205
Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system
Kogure, K., Akita, H., Yamada, Y., & Harashima, H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.007 · Cited by 187
Targeted gene delivery of BMPR2 attenuates pulmonary hypertension
Reynolds, A. M., Holmes, M. D., Danilov, S. M., & Reynolds, P. N. (2012) · European Respiratory Journal · doi:10.1183/09031936.00187310 · Cited by 186
Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
Breyer, B. N., Jiang, W., Cheng, H., Zhou, L., Paul, R., Feng, T., & He, T. (2001) · Current Gene Therapy · doi:10.2174/1566523013348689 · Cited by 167
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
Coughlan, L., Alba, R., Parker, A. L., Bradshaw, A. C., McNeish, I. A., Nicklin, S. A., & Baker, A. H. (2010) · Viruses · doi:10.3390/v2102290 · Cited by 139
Retrovirus‐mediated gene delivery into male germ line stem cells
Nagano, M. C., Shinohara, T., Avarbock, M. R., & Brinster, R. L. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01606-9 · Cited by 133
Recent advances in liposome technologies and their applications for systemic gene delivery
Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00108-7 · Cited by 126
Cationic versus Neutral Microbubbles for Ultrasound-mediated Gene Delivery in Cancer
Wang, D. S., Panje, C. M., Pysz, M. A., Paulmurugan, R., Rosenberg, J., Gambhir, S. S., Schneider, M., & Willmann, J. K. (2012) · Radiology · doi:10.1148/radiol.12112368 · Cited by 115
PAMAM Dendrimers for siRNA Delivery: Computational and Experimental Insights
Pavan, G. M., Posocco, P., Tagliabue, A., Maly, M., Malek, A. V., Danani, A., Ragg, E. M., Catapano, C. V., & Pricl, S. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200903258 · Cited by 103
Adeno-associated virus for cancer gene therapy.
Ponnazhagan, S., Curiel, D. T., Shaw, D. R., Alvarez, R. D., & Siegal, G. P. (2001) · PubMed · Cited by 98
Lipid Carrier Systems for Targeted Drug and Gene Delivery
Hashida, M., Kawakami, S., & Yamashita, F. (2005) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.53.871 · Cited by 97
Dual-purpose magnetic micelles for MRI and gene delivery
Wang, C., Ravi, S., Martinez, G. V., Chinnasamy, V., Raulji, P., Howell, M., Davis, Y., Mallela, J. P., Seehra, M. S., & Mohapatra, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.030 · Cited by 95
Arsianti, M., Lim, M., Marquis, C. P., & Amal, R. (2010) · Biomacromolecules · doi:10.1021/bm100748p · Cited by 91
Ultrasound and microbubble-assisted Gene Delivery: Recent Advances and Ongoing Challenges
Delalande, A., Postema, M., Mignet, N., Midoux, P., & Pichon, C. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.100 · Cited by 80
Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo
Kidd, M. E., Shin, S., & Shea, L. D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.036 · Cited by 79
Gene Delivery Systems: Recent Progress in Viral and Non-Viral Therapy
Cevher, E., Demir, A. S., & Çağlar, E. Ş. (2012) · InTech eBooks · doi:10.5772/53392 · Cited by 73
Liposomes as a gene delivery system
Ropert, C. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000200004 · Cited by 54
Pędziwiatr‐Werbicka, E., Shcharbin, D., Malý, J., Maly, M., Zaborski, M., Gabara, B., Ortega, P., de la Mata, F. J., Gómez, R., Muñoz‐Fernández, M. Á., et al. (2012) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2012.1369 · Cited by 39
Nanomagnetic Gene Transfection for Non-Viral Gene Delivery in NIH 3T3 Mouse Embryonic Fibroblasts
Fouriki, A., & Dobson, J. (2013) · Materials · doi:10.3390/ma6010255 · Cited by 28
Savard, S., Lavoie, P., Villeneuve, C., Agharazii, M., Lebel, M., & Larivière, R. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr641 · Cited by 27
Davtyan, H., Ghochikyan, A., Movsesyan, N., Ellefsen, B., Petrushina, I., Cribbs, D. H., Hannaman, D., Evans, C. F., & Agadjanyan, M. G. (2012) · Neurodegenerative Diseases · doi:10.1159/000333359 · Cited by 25
Zhou, M., Wang, L., Su, W., Tong, L., Liu, Y., Fan, Y. L., Luo, N., Zheng, Y., Zhao, H., Xiang, R., et al. (2012) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2012.1442 · Cited by 19
Kang, J., Tachibana, Y., Obika, S., Harada‐Shiba, M., & Yamaoka, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.030 · Cited by 18
Gene delivery to pancreatic exocrine cells in vivo and in vitro
Houbracken, I., Baeyens, L., Ravassard, P., Heimberg, H., & Bouwens, L. (2012) · BMC Biotechnology · doi:10.1186/1472-6750-12-74 · Cited by 17
Fernandes, A., Easton, A. C., Silva, M. A. D. S., Schumann, G., Müller, C. P., & Desriviéres, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08028.x · Cited by 17
Current Advances in Vehicles for Brain Gene Delivery
Zhang, X., Zhao, L., Wu, J., Dong, H., Xu, F., Gong, G., & Hu, Y. (2012) · Current Gene Therapy · doi:10.2174/156652312802762590 · Cited by 11
Franceschi, R. T., & Ge, C. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-104-8_10 · Cited by 10
Nanus, D. M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1586 · Cited by 8
Advances in Liposome-Based Targeted Gene Therapy of Cancer
Hsu, J. L., Chao, C.-H., Xie, X., & Hung, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397833-2.00005-4 · Cited by 4
Gene Delivery by Direct Injection (Microinjection) Using a Pulsed-Flow SystemPreprint
Dean, D. A. (2006) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot4653 · Cited by 4
Munisso, M. C., Mahara, A., Tachibana, Y., Kang, J., Obika, S., & Yamaoka, T. (2012) · Advances in science and technology · doi:10.4028/www.scientific.net/ast.86.86 · Cited by 4
Design and Development of Light-Sensitive Chitosan-Based Nanocarriers for Gene Delivery
Duceppe, N., & Tabrizian, M. (2012) · Advances in science and technology · doi:10.4028/www.scientific.net/ast.86.75 · Cited by 3
Research works printed but not linked: 3
- Peng, 2012, Short noncoding DNA fragment improve efficiencies of in vivo electroporation-mediated gene transfer, J Gene Med, 563
- Cao, 2012, Gene gun bombardment with DNA-coated golden particles enhanced the protective effect of a DNA vaccine based on thioredoxin glutathione reductase of Schistosoma japonicum, J Biomed Biotecnol, 1
- Ginsberg AA, Shen X, Hutnick NA, Weiner DB. Improvement of DNA vaccines by electroporation. Available from: http://www.researchgate.net/publication/225843247_Improvement_of_DNA_Vaccines_by_Electroporation [Last accessed on 2012 Nov 26].
Cited by
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
Loureiro, A., & da Silva, G. J. (2019) · Antibiotics · doi:10.3390/antibiotics8010018 · Cited by 129
Metadata
- Authors
- Valsalakumari, J., Baby, J., Bijin, E., Constantine, I., Manjila, S., & Pramod, K.
- Venue
- International Journal of Pharmaceutical Investigation
- Publisher
- Manuscript Technomedia LLP
- Published
- 2013
- Volume
- 3
- Issue
- 1
- Pages
- 1
- ISSN
- 2230-973X
- PMC
- PMC3687232
- Cited by
- 48
- References
- 44
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.